A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma
- Bernicker, Eric H. (PI)
- Abdelrahim, Maen (Key Personnel)
- Chang, Jenny C. (Key Personnel)
- Heyne, Kirk (Key Personnel)
- Niravath, Polly A. (Key Personnel)
- Singh, Monisha (Key Personnel)
Project: Clinical Trial